Sientra reported 11.26M in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abiomed ABMD:US $ 207.4M 12.23M
Align Technology ALGN:US $ 758.54M 81.44M
Antares Pharma ATRS:US $ 28.54M 2.9M
Cooper Companies COO:US $ 516.1M 29M
Dexcom DXCM:US $ 417.1M 73.2M
Globus Medical GMED:US $ 187.17M 14.85M
Insulet PODD:US $ 182.7M 15.2M
Integra Lifesciences IART:US $ 249.45M 25.02M
Johnson & Johnson JNJ:US $ 15725M 440M
Nuvasive NUVA:US $ 216.55M 17.11M
Orasure Technologies OSUR:US $ 30.67M 7.65M
Rockwell Medical RMTI:US $ -0.26M 0.66M
Sientra SIEN:US 11.26M 1.04M
Staar Surgical STAA:US $ 49.2M 10.06M
Stryker SYK:US $ 2712M 281M
Teleflex TFX:US $ 397.56M 53.03M
Zimmer Biomet Holdings Inc ZBH:US $ 1.45B 114.3M